Skip to main content

Advertisement

Log in

Changes in the prescribing pattern of antidepressant drugs in elderly patients: an Italian, nationwide, population-based study

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Background

Despite the high use of antidepressants (ADs) among the elderly, there is limited information about the prescribing pattern of these drugs in the Italian elderly population. The aim of this study was to analyze the trend in the use of ADs in the Italian elderly patients in the years 2003-2009, and specifically, to evaluate rates and predictors of AD treatment discontinuation in depressed older patients.

Methods

The nationwide general practice Health Search Database (HSD) was used to identify AD users aged 65 years old and over from 2003 to 2009. ADs were categorized as (1) selective serotonin reuptake inhibitors (SSRIs); (2) serotonin-norepinephrine reuptake inhibitors (SNRIs); (3) tricyclic antidepressants (TCAs); (4) noradrenergic and specific serotonergic antidepressants (NaSSAs); and (5) other ADs. Incidence and prevalence of AD use per 1,000 inhabitants was calculated by drug class and single compound. We also measured rates and predictors of AD discontinuation (i.e., treatment gap ≥ 60 days) during the first year of therapy.

Results

Overall, 39,557 AD users ≥65 years (17 % of the total HSD elderly population) were included in the study. SSRIs were increasingly and most frequently prescribed ADs (102.7-195.3 per 1,000 over seven years). The most common indications for AD use were depression and anxiety. Overall, 14 % of AD users continued their AD medication without treatment gaps, 27 % were intermittent AD users and 58 % discontinued their ADs during the first year of follow-up. Specific AD classes such as TCAs and ‘other ADs were found to be predictors of discontinuation. In depressed patients, the use of NaSSas, TCAs and ‘other ADs as well the concomitant use of >5 drugs (other than ADs) and living in Southern Italy were more likely to predict discontinuation.

Conclusion

ADs, especially SSRIs, are widely and increasingly prescribed in elderly Italian patients in recent years. The observed high AD discontinuation rates are likely to impact the achievement of a therapeutic endpoint in depressed patients. Patients who are at high risk of AD discontinuation such as those receiving multi-drug therapy or living in Southern Italy should be monitored more closely to improve benefits of AD treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Unutzer J (2007) Clinical practice. Late-life depression. N Engl J Med 357(22):2269–2276

    Article  CAS  PubMed  Google Scholar 

  2. Castro-Costa E, Dewey M, Stewart R, Banerjee S, Huppert F, Mendonca-Lima C et al (2007) Prevalence of depressive symptoms and syndromes in later life in ten European countries: the SHARE study. Br J Psychiatry 191:393–401

    Article  CAS  PubMed  Google Scholar 

  3. Ereshefsky L, Saragoussi D, Despiegel N, Hansen K, Francois C, Maman K (2010) The 6-month persistence on SSRIs and associated economic burden. J Med Econ 13(3):527–536

    Article  PubMed  Google Scholar 

  4. Trifiro G, Tillati S, Spina E, Ferrajolo C, Alacqua M, Aguglia E et al (2013) A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. Eur J Clin Pharmacol 69(2):227–236

    Article  PubMed  Google Scholar 

  5. Mann JJ (2005) The medical management of depression. N Engl J Med 353(17):1819–1834

    Article  CAS  PubMed  Google Scholar 

  6. Trifiro G, Barbui C, Spina E, Moretti S, Tari M, Alacqua M et al (2007) Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. Pharmacoepidemiol Drug Saf 16(5):552–559

    Article  CAS  PubMed  Google Scholar 

  7. Berardi D, Menchetti M, De Ronchi D, Rucci P, Leggieri G, Ferrari G (2002) Late-life depression in primary care: a nationwide Italian epidemiological survey. J Am Geriatr Soc 50(1):77–83

    Article  PubMed  Google Scholar 

  8. Berardi D, Leggieri G, Ceroni GB, Rucci P, Pezzoli A, Paltrinieri E et al (2002) Depression in primary care. A nationwide epidemiological survey. Fam Pract 19(4):397–400

    Article  PubMed  Google Scholar 

  9. Parabiaghi A, Franchi C, Tettamanti M, Barbato A, D’Avanzo B, Fortino I et al (2011) Antidepressants utilization among elderly in Lombardy from 2000 to 2007: dispensing trends and appropriateness. Eur J Clin Pharmacol 67(10):1077–1083

    Article  CAS  PubMed  Google Scholar 

  10. Balestrieri M, Carta MG, Leonetti S, Sebastiani G, Starace F, Bellantuono C (2004) Recognition of depression and appropriateness of antidepressant treatment in Italian primary care. Soc Psychiatry Psychiatr Epidemiol 39(3):171–176

    Article  PubMed  Google Scholar 

  11. Marengoni, A., Bianchi, G., Nobili, A., Tettamanti, M., Pasina, L., Corrao, S. et al., Prevalence and characteristics of antidepressant drug prescriptions in older Italian patients. Int Psychogeriatr: p. 1-8

  12. Kuyken W, Byford S, Byng R, Dalgleish T, Lewis G, Taylor R et al (2012) Study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment in the prevention of depressive relapse/recurrence: the PREVENT trial. Trials 11:99

    Article  Google Scholar 

  13. National Institute for Health & Clinical Excellence (2010) Depression: The Treatment and Management of Depression in Adults (Updated Edition)

  14. World Health Organisation. Duration of antidepressant treatment. 2012 [cited 16.12.13]; Available from: http://www.who.int/mental_health/mhgap/evidence/depression/q2/en/index.html.

  15. Lapi F, Simonetti M, Michieli R, Pasqua A, Brandi ML, Frediani B et al (2012) Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care. Bone 50(1):85–90

    Article  CAS  PubMed  Google Scholar 

  16. Cricelli C, Mazzaglia G, Samani F, Marchi M, Sabatini A, Nardi R et al (2003) Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med 25(3):254–257

    Article  PubMed  Google Scholar 

  17. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V et al (2009) Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 120(16):1598–1605

    Article  CAS  PubMed  Google Scholar 

  18. Trifiro G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M et al (2012) Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study. Ann Rheum Dis 72(5):694–700

    Article  PubMed  Google Scholar 

  19. Melfi C, Holleman E, Arthur D (1995) Katz B Selecting a patient characteristics index for the prediction of medical outcomes using administrative claims data. J Clin Epidemiol 48(7):917–926

    Article  CAS  PubMed  Google Scholar 

  20. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383

    Article  CAS  PubMed  Google Scholar 

  21. Aguglia E, Ravasio R, Simonetti M, Pecchioli S, Mazzoleni F (2012) Use and treatment modalities for SSRI and SNRI antidepressants in Italy during the period 2003-2009. Curr Med Res Opin 28(9):1475–1484

    Article  CAS  PubMed  Google Scholar 

  22. StataCorp (1999) Stata Statistical Software

  23. Poluzzi E, Motola D, Silvani C, De Ponti F, Vaccheri A, Montanaro N (2004) Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement. Eur J Clin Pharmacol 59(11):825–831

    Article  PubMed  Google Scholar 

  24. Percudani M, Barbui C, Fortino I, Petrovich L (2004) Antidepressant drug use in Lombardy, Italy: a population-based study. J Affect Disord 83(2–3):169–175

    Article  PubMed  Google Scholar 

  25. Bauer M, Monz BU, Montejo AL, Quail D, Dantchev N, Demyttenaere K et al (2008) Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. Eur Psychiatry 23(1):66–73

    Article  PubMed  Google Scholar 

  26. Spina E, Trifiro G, Caraci F (2012) Clinically significant drug interactions with newer antidepressants. CNS Drugs 26(1):39–67

    Article  CAS  PubMed  Google Scholar 

  27. Trifiro G, Dieleman J, Sen EF, Gambassi G, Sturkenboom MC (2010) Risk of ischemic stroke associated with antidepressant drug use in elderly persons. J Clin Psychopharmacol 30(3):252–258

    Article  CAS  PubMed  Google Scholar 

  28. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R et al (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373(9665):746–758

    Article  CAS  PubMed  Google Scholar 

  29. Ferguson JM (2001) SSRI Antidepressant Medications: Adverse Effects and Tolerability. Prim Care Companion J Clin Psychiatry 3(1):22–27

    Article  PubMed Central  PubMed  Google Scholar 

  30. FDA, FDA Drug Safety Communication: Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses (2013) FDA: Maryland

  31. FDA, FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide) (2012)

  32. Dolder CR, Nelson MH, Iler CA (2012) The effects of mirtazapine on sleep in patients with major depressive disorder. Ann Clin Psychiatry 24(3):215–224

    PubMed  Google Scholar 

  33. Pfizer, GD-mirtazapine OD Monograph (2012)

  34. Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R et al (2011) Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet 378(9789):403–411

    Article  CAS  PubMed  Google Scholar 

  35. Meijer WE, Heerdink ER, Leufkens HG, Herings RM, Egberts AC, Nolen WA (2004) Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol 60(1):57–61

    Article  PubMed  Google Scholar 

  36. Olfson M, Marcus SC, Tedeschi M, Wan GJ (2006) Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry 163(1):101–108

    Article  PubMed  Google Scholar 

  37. Mounsey AL, Matthew LG, Slawson DC (2005) Herpes zoster and postherpetic neuralgia: prevention and management. Am Fam Physician 72(6):1075–1080

    PubMed  Google Scholar 

Download references

Conflict of interest

All authors have no conflicts of interests to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gianluca Trifirò.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sultana, J., Italiano, D., Spina, E. et al. Changes in the prescribing pattern of antidepressant drugs in elderly patients: an Italian, nationwide, population-based study. Eur J Clin Pharmacol 70, 469–478 (2014). https://doi.org/10.1007/s00228-013-1636-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-013-1636-z

Keywords

Navigation